BMS1 ribosome biogenesis factor pseudogene 20 (BMS1P20)

BMS1P20 is a transcribed pseudogene, meaning that while its RNA may be expressed, it does not encode a functional protein and is not considered an active molecular target for therapeutics. It appears to have arisen from duplication of the BMS1 homolog of yeast ribosome assembly protein, but it has lost protein-coding ability. Functional BMS1 plays a role in ribosome biogenesis, specifically in the 90S pre-ribosome and assembly of ribosomal subunits, but the pseudogene BMS1P20 itself is not known to participate in these processes. Alternate names reported include IGL, IGLV, and IGLV1, though these may cause confusion with immunoglobulin genes. There is no evidence that BMS1P20 is a receptor, enzyme, or other druggable target, nor any links to disease, biomarkers, or safety concerns. While the name “BMS1P20” closely resembles gene and protein targets, it is specifically classified as a pseudogene and is not a canonical therapeutic target. There is some confusion because aliases such as IGL or IGLV refer to immunoglobulin loci, but BMS1P20 is distinct from functional immunoglobulin genes. If you are seeking a medically or pharmacologically relevant target, BMS1 ribosome biogenesis factor (BMS1, not BMS1P20) is the functional gene with established biological roles.

Other names

IGLIGLVIGLV1